The Evolution of Phlebotomy 

Video length: 46 minutes


Have you ever wondered how we came from bloodletting and leeches to present-day phlebotomy? This presentation is going to walk you through the history and what has led us to some of the advancements in the field of phlebotomy, including safety and regulations.


Erin Peper, M.S., PBT(ASCP)

Program Director, Mayo Clinic School of Health Sciences Phlebotomy Technician Program 
Division of Clinical Core Laboratory Services 
Mayo Clinic, Rochester, Minnesota 

Learning objectives

Upon completion of this activity, participants should be able to:

  • Describe the introduction of safety devices on venipuncture equipment.
  • Recognize regulatory agencies, certifying bodies, and standard practices associated with phlebotomy.
  • Summarize how phlebotomy has benefitted from advancements in medicine.

Intended audience

This series is appropriate for phlebotomists, phlebotomy managers, phlebotomy educators, and other patient care staff involved in specimen collection.


The following types of credit are offered for this event:


Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 1.0 P.A.C.E.® contact hour.

State of Florida

Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for the Clinical Laboratory Sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for General credit. This program has been approved for 1.0 contact hour.

To obtain credit

1. Watch the video.

2. Complete the posttest and evaluation that launches immediately following the video.

3. Generate and print your certificate(s).

Level of instruction for this program is basic.

Credit for this recording expires on: 2/15/25

Faculty disclosure

Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.


Contact us:

MCL Education

This post was developed by our Education and Technical Publications Team.